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Abstract. Cytoplasmic dynein purified by nucleotide
dependent microtubule affinity has significant minus
end-directed vesicle motor activity that decreases with
each further purification step. Highly purified dynein
causes membrane vesicles to bind but not move on
microtubules. We exploited these observations to de-
velop an assay for factors that, in combination with
dynein, would permit minus end-directed vesicle mo-
tility. At each step of the purification, non-dynein
fractions were recombined with dynein and assayed
for vesicle motility. Two activating fractions were iden-
YTOPLAsmic dynein is a microtubule-based, mechano-
chemical ATPase found in virtually all animal cells
(Amos, 1989; Collins and Vallee, 1989 ; Euteneuer
et al., 1988; Gilbert and Sloboda, 1989; Koonce and McIn-
tosh, 1990; Lye et al., 1987; Neely and Boekelheide, 1988;
Paschal et al., 1987; Schnapp and Reese, 1989; Schroer et
al., 1989; Verde et al., 1991) . Ultrastructurally and bio-
chemically similar to axonemal dynein, cytoplasmic dynein
is a microtubule-activated ATPase that powers movement to-
ward the minus ends of tubulin filaments (Paschal et al.,
1987; Paschal and Vallee, 1987; Sale and Satir, 1977) . While
axonemal dyneins function solely in ciliary and flagellar mo-
tility, serving to drive sliding of adjacent microtubule dou-
blets, cytoplasmic dyneins are believed to power a variety of
microtubule-based motile processes. As in vitro, cytoplasmic
dynein within cells is thought to cause minus end-directed
movementof membrane vesicles (Schnapp and Reese, 1989;
Schroer et al., 1989). Examples of minus end motility in-
clude retrograde axonal transport, movement of endocytic
cargo from the endosome to the lysosome (Gruenberg et al.,
1989), and transport from the basolateral to apical surface
of epithelia (Bomsel et al., 1990; reviewed in Schroer and
Sheetz, 1991). Cytoplasmic dynein is associated with kineto-
chores and with microtubules of the mitotic spindle (Pfarr
et al., 1990; Steuer et al., 1990; Wordeman et al., 1991),
suggesting a role in chromosome-to-pole movements during
prometaphase and anaphase as well as overall spindle motil-
ity. Dynein may also function as a force producer for neurite
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tified by this method. One, called Activator I, copuri-
fied with 20S dynein by velocity sedimentation but
could be separated from it by ion exchange
chromatography. Activator I increased only the fre-
quency of dynein-driven vesicle movements. Activator
II, sedimenting at 9S, increased both the frequency
and velocity of vesicle transport and also supported
plus end movements. Our results suggest that dynein-
based motility is controlled at multiple levels and pro-
vide a preliminary characterization of two regulatory
factors.
extension and other microtubule-dependent cytoplasmic re-
arrangements. Given the range of possible transport func-
tions, cytoplasmic dynein activity is likely to be subject to
a host of control mechanisms.
Purified cytoplasmic dynein produces movement of mi-
crotubules on glass coverslips and plastic beads on microtu-
bules by virtue of its well-characterized microtubule-stim-
ulated ATPase activity (Euteneuer et al., 1988; Lye et al.,
1987; Paschal et al., 1987). Such assays are useful for deter-
mining kinetic parametersofenzyme activity and for follow-
ing dynein through its purification but do not necessarily
provide insight into intracellular function. With this in mind,
we have developed an in vitro assay that allows us to study
the vesicle motor activity of cytoplasmic dynein (Schroer et
al., 1988; Schroer et al ., 1989). Assay samples are com-
prised of purified microtubules and membrane vesicles ex-
tracted with high salt to prevent their movement unless a
soluble fraction is added. Activity of the soluble fraction is
measured as the frequency of vesicle movements observed
by video-enhanced differential interference contrast (DIC)'
microscopy.
Using the vesicle motility assay, cytoplasmic dynein was
shown to be necessary for minus end-directed movement
(Schroer et al., 1989) . A dynein-containing cytosol from
chick embryo fibroblasts moved vesicles predominantly to-
ward the minus ends of microtubules, and vanadate-medi-
ated UV photocleavage (Gibbons et al., 1987), a treatment
that inactivates dynein selectively (Porter, M. E ., P M.
Grissom, C. M . Pfarr, and J. R. McIntosh. 1987. J. Cell
Biol. 105:33a), resulted in profound inhibition ofminus end
transport. Addition of purified dynein to inactivated cytosol
1. Abbreviation used in this paper: DIC, differential interference contrast.completely restored vesicle motility although dynein by it-
self had little vesicle motor activity. We concluded that
dynein was necessary but not sufficientfor minus end vesicle
transport and that other factors in the cytosol played an im-
portant role.
We have now identified and isolated from embryonic
chicken brain two soluble factors that allow purified cyto-
plasmic dynein to move vesicles. These factors are present
in partially purified dynein preparations but are successively
removed during later steps in the purification. Dynein pre-
pared by ATP-dependent microtubule affinity contains both
activators and consequently has a high level of minus end
vesicle motor activity. Vesicle motility is significantly re-
duced after velocity sedimentation and is undetectable after
the finalpurification step, ion-exchange chromatography, al-
though the highly purified dynein is still active in a microtu-
bule gliding assay. This stepwise loss ofvesicle motor activ-
ity allowed us to identify two activators, Activator I, which
is removed by ion exchange chromatography and Activator
II, which separates from dynein during velocity sedimenta-
tion. Activators I and II may represent merely a subset of
the regulatory factors governing dynein-based intracellular
motility.
Materials andMethods
Materials
Chick embryo fibroblasts were generously provided by Drs. Milton and
Sondra Schlesinger at Washington University School of Medicine (St.
Louis, MO). Taxol was provided by Dr. Matthew Suffness at the National
Cancer Institute (Frederick, MD). Reagents for polyacrylamide gel elec-
trophoresis and the Bradford protein assay were purchased from Bio-Rad
Co. (Richmond, CA). 5-Bromo-4-chloro-3-indolyl phosphate for the alka-
line phosphatase reaction was from Calbiochem-Behring Corp. (San Diego,
CA). Ultrapure sucrose was obtained from ICN Biomedicals (Cleveland,
OH) . All other chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO). Fertilized chicken eggs were obtained from Spafas, Inc.
(Roanoke, IL) . Monoclonal anti-kinesin antibody SUK4 was a kind gift of
Dr. Jon Scholey (University of California, Davis, CA). Monoclonal anti-
actin antibody C4 was generously provided by Dr. J. Lessard (University
ofCincinnati, Cincinnati, OH) . The MonoQ column was from Pharmacia
LKB (Piscataway, NJ). Amicon 30 microconcentrators were purchased
from Amicon Corp. (Danvers, MA).
CytoplasmicDynein Purification
Brains from 11-12-d old chick embryos (=0.25 g/brain) were dissected,
rinsed twice in PBS, then rinsed in homogenization buffer (35 mM ICPipes,
pH 7.2, 5 MM MgS04, 1 mM EGTA, and 0.5 mM EDTA) . The wet brain
pellets were divided into 5-, 10-, or 20-g aliquots, flash frozen in liquid NZ
and stored at -80°C.
PreparationofATPRelease. 20 g ofbrains were rapidly thawed at 37°C
and transferred to a Douncehomogenizer (on ice). 20 ml ofhomogenization
buffer containing a protease inhibitor cocktail (Dabora and Sheetz, 1988)
and 1 mM DTT was added and the brains were homogenized (10 strokes
with atype A pestle), allowed tostand for 5 minon ice, thenrehomogenized
(10 strokes with a type A pestle). The homogenate was centrifuged at 4°C
for 15 min, 16.5 k rpm (SA600 rotor; Sorvall Instruments, DuPont Co.,
Newton, CT). The supernatant was immediately removed and subjected to
ultracentrifugation at 4°C for 30 min at 182,000 g. The supernatant was
removed and 0.5 mM ATP, 1 mM GTP, and 20 AM taxol were added to
induce microubulepolymerization. The mixture was incubated at 37°C for
30 min with occasional gentle mixing. The volume (V) of the sample was
noted, then the sample was subjected to ultracentrifugation at 25°C for 30
min at 182,000 g to pellet microubules. Meanwhile, phosphocellulose-
purifiedbovine tubulin (Williams and Lee, 1982; enough to give a tubulin
concentration of 0.25 mg/nd in volume V) was thawed, 1 mM GTP, and
20 pM taxol were added, and the microubules polymerized by incubating
at 37°C for 15 min. The polymerized microtubules were stored at room
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temperature for less than 30 min until subsequent use. Following ultracen-
trifugation the brain supernatant was removed, made 4 mM in AMP-PNP
and MgSO4, the bovine microubules were added, and the sample was in-
cubated atroom temperature for 20 minwith occasional gentle mixing. The
sample was then layered onto atwo-step sucrose gradient composed of 12.5
and 25% sucrose in homogenization buffer containing 1 mM GTP and
20 pM taxol. (The volume ofthe gradient was usually 5 to 10 ml, such that
a 39 ml SW 28 tube would be completely filled when the gradientwas over-
layered with the nricrotubule/supernatant mixture.) The gradient was then
subjected to ultracentrifugation at 25°C for 45 min at 105,000 g. The final
supernatant and the gradient steps were removed by aspiration and the
pearlescent microtubule pellet was resuspended in homogenization buffer
(total volume used was 0.1 to 0.15 x V) containing 10 mM ATP, 5 mM
(additional) MgSO4, 1 mM GTP, and 20 pM taxol (ATP release buffer).
The microtubule pellet was resuspended as follows. Using a P-1,000 pipet-
man, 0.5-ml aliquots of ATP release buffer were gently pipetted at the edge
of the pellet. The release buffer was repeatedly triturated to break up the
pellet, taking great careto avoid bubble formation. The resuspended micro-
tubules were transferred into a thickwall SW50.1 tube. Multiple fresh ali-
quots of release buffer were added to the pellet until it was completely
resuspended. The microubules were incubated at room temperature for 15
min, then subjected to ultracentrifugation at 25°C for 30 min at 188,000g.
The final supernatant (ATP release) was removed and immediately placed
on ice. Approximately 20% of total dynein was recovered in theATP release
(Gill et al., in press).
Velocity Sedimentation. The ATP release (2.5 to 3 ml total) was then
layeredontotwo 11.5 ml, 5-20% lineargradients ofsucrose inhomogeniza-
tion buffer containing 0.5 mM ATP and 1 mM DTT. The gradients were
centrifuged at 4°C for 13.5 h at 145,000 g in a SW 40 rotor. Sedimentation
standards were catalase (11.3S) and thyroglobulin (19S). The bottom ofthe
tubewaspunctured with a 19 gaugeneedle, takingcare to avoidthe microtu-
bule pellet, then 1.3 ml fractions were collected. The fractions were im-
mediately analyzed by SDS-PAGE.
To analyze motor activity of the gradient fractions it was necessary to
remove sucrose. A 0.5 ml aliquot ofa fraction (or a pool of fractions) was
diluted with 1.5 ml homogenization buffer and concentrated by ultrafiltra-
tion in an Amicon 30 microconcentrator. This was repeated to arrive at a
final volume of 100-200 pl, having a sucrose concentration of<1.25% and
protein concentration of 50-100 mg/ml.
MonoQ Chromatography. The 20S (or 9S) sucrose gradient fractions
were pooled, passed through a 0.2-,um filter, and loaded onto a HR5/5
MonoQ column. The column was run at a flow rate of 1 ml/min and moni-
tored by absorbanceat 280 ant. After loading, thecolumn was washed with
homogenizationbuffer until theabsorbance returnedto baseline(10-15 ml).
Material was eluted from the column with a 15-ml linear gradient of 0 to
250 mM KCl followed by a 25-ml linear gradient of250 to 400 mM KCI.
Fractions of 1 ml were collected or the fraction collector was manually ad-
vanced after each peak ofabsorbance. At the end ofthe run the column was
washed with 1 M KCI .
The fractions comprising each peak were pooled, then desalted and con-
centrated in an Amicon 30 microconcentrator. Only 0.5 nil of MonoQ
dynein (peak 2) was used because of its high concentration (x.14 mg/ml)
after chromatography. To ensure that the final KCI concentration was 450
mM each pool was subjected to multiple cycles ofdilution (with homogeni-
zation buffer) and reconcentration. The final volume of each pool was 50
to 150 pl having protein concentrations of =200 ug/ml. The concentrated
MonoQ pools were stored on ice for further use.
UVPhotocleavage
Vanadate-mediated UV photocleavage was performed as described previ-
ously (Schroer et al., 1989).
VesiclePreparation
KI-washed chick embryo fibroblast membranes were isolated and treated
with 0.6 M KI to extract weakly associated proteins (including kinesin and
dynein) as described (Schroer et al., 1989). 40 pl of crude membranes were
KI extracted, then resuspended in 30 pl homogenizationbuffer. The protein
concentration was 3 mg/ml. Membranes were used at a dilution of ti1:5 to
give a final concentration of 0.65 mg/ml in the motility assay.
Motility Assays
Vesicle MotorActivity. In the assays described below, the microtubule sub-
strate and vesicles are prepared in a standardized manner so the activity of
1310any soluble sample is reproducible fromexperiment to experiment (Schroer
et al., 1988; Schroer et al., 1989). Each video field contained =200 Am
of microtubule polymer; vesicles were used at 0.65 mg/ml. In the absence
ofsoluble motors vesiclemovements arenot observed. Samples were exam-
inedusingvideo-enhancedcontrast, DICmicroscopyasdescribed (Schnapp,
1986). Data were recordedon 3/4 in U-matic or SVHSvideocassettes. Im-
ages from the video monitor were recorded on Plus-X film (ASA125)
and printed through a 50 line per inch Ronchi ruling to minimize video
scan lines.
Preparation of Randomly Oriented Microtubule Substrate. Vesicles
stuck to gliding microtubules are difficult to distinguish from vesicles being
translocated along stationary microtubules, producing artifactually high
measurements oforganelle motor activity. To avoid this problem we devel-
oped a procedure for the preparation of an immobilized microtubule sub-
strate. Microtubule gliding was not observed in samples prepared in this
manner.
A 20-Al aliquot of freshly thawed bovine brain tubulin (5 mg/nil) was
polymerized by the addition of 5 Al of homogenization buffer containing 5
mM GTP and 100 AM taxol. The mixture wasincubated for 15 min at 37°C
and then added to 175 Al homogenization buffer containing 1 mM GTP and
20 AM taxol, mixing by gentle trituration. The diluted microtubule stock
(160 Al) was thenadded to 12 nil ofhomogenization buffer plus 1 mM GTP
and 20 AM taxol that was prewarmed to 37°C.
Polymerized microtubules were sedimented onto eight coverslips as fol-
lows. 50 ml round-bottom centrifuge tubes were plugged with =8 ml RTV
silicon rubber (Dow-Coming Co., Midland MI) as a level coverslip support
forcentrifugation. Round coverslips (7/8-in diam) wereprewashed with two
cycles of 25% HN03 and 2 M NaOH, rinsed extensively with distilled wa-
ter, and baked dry. A circle of=8 mm (inner diameter) made from silicon
high vacuum grease (Dow Coming Co., Midland MI) was drawn on each
coverslip to serve as a sample well and reduce lateral shearing. Coverslips
were then placed into the eightplugged centrifuge tubes and each was over-
layered with 1.5 ml ofthe polymerizedmicrotubulemixture. The tubes were
centrifuged at 25°C for 10 min at 7,000 rpm (HS-4 rotor) .
Coverslips were removed from the centrifuge tubes by vacuum using a
pasteur pipet tipped with silicon rubber tubing. Care was taken to ensure
that a pool of liquid remained in the central well on each coverslip since
drying of the microtubule substrate caused a marked loss of activity. The
coverslips were placed onstands in a humidified chamber. Each samplewell
was blocked with heat-inactivated FCS that had been dialyzed against
homogenization buffer, made 1 mM in GTP and 20 AM in taxol, and
clarified by centrifugation for 10 min at 27 psi in an airfuge (Beckman In-
struments Inc., Palo Alto, CA). 10 Al of the buffer in each coverslip well
was removed and immediately replaced with 10 Al of serum, then incubated
for 10 min at room temperature. At the end of the incubation 1O Al of the
liquid in the well was removed and immediately replaced with 20 Al of
homogenization bufferplus 1 mM GTP and 20 Al taxol. Thecoverslips were
left in the humidified chamber until further use. Microscopic analysis re-
vealed the microubules to be evenly dispersed across the central well.
Sample Preparation. The standard sample recipe was 1.5 A1 KI-washed
membranes, 1 Al carrier protein (FCS prepared as above), 0.7 Al of 20 mM
ATP and 4 AI of a motor sample. Motor samples were mixtures of 208 or
MonoQ-purified dynein and a sucrosegradient fraction (or pool), a MonoQ
pool, or buffer alone (homogenization buffer plus 1 mM GTP and 20 AM
taxol). The sample waspremixed and drawnup into a pipet (P20pipetman),
ready to dispense. The buffer in the central well ofone coverslip (prepared
as above) was removed completely and then immediately replaced with the
sample. The cwerslip was then inverted onto a second coverslip, sealed
with VALAP (equal parts Vaseline, lanolin, and paraffin; see Brady et al.,
1985), swabbed with ethanol, and thendistilled water to removebuffer salts,
viewed in the video microscope, and scored for vesicle motor activity as
describedpreviously (Schroer et al., 1988). Video fields were selected with
a microtubule density of=200-Am-polymer length per 400 pmz area (one
video field).
Directionality Assay . Assays were performed on microtubules regrown
from isolated centrosomes as described previously (Schroer et al., 1989),
except that a motor sample (see above) was used instead of chick embryo
fibroblast cytosol .
Vesicle Motor Activity. This was determined by counting the number of
vesicle movements that occurred in one video field in a 2-4-min interval.
The data presented are the mean (t SEM) of at least six video fields from
two or more experiments performed on separate occasions (see Schroer et
al., 1988); in most cases the total number of video fields scored was 10 or
more. A movement was considered to be any unidirectional vesicle translo-
cation over a distance greater than 1 Am. Only movements faster than 0.3
Am/s were considered in the activitymeasurements. Velocity measurements
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on randomly selected vesicles from at least two independent experiments
were made using the Measure program of Dr. Steven Block (Sheetz et
al., 1986). The velocity analysis included vesicle movements slower than
0.3 Am/s.
Microtubule Gliding . These activities of 20S and MonoQ dynein were
assayed as described (Vale et al., 1985).
SDS-PAGE, Immunoblot, and Protein Assay
Samples were analyzed by SDS-PAGE as described (Laemmli, 1970). Im-
munoblotting was performed as described (Towbin et al., 1979) using anti-
kinesin mAb SUK4 (Ingold et al., 1988), anti-actin mAb C4 (Lessard,
1988), anti-dynein mAbs 440.1 and 70.1, or mAb 150.1 against the M,
150,000component of20S dyneinand MonoQ peak 3 (Steuer et al., 1990) .
Goat anti-mouse second antibody was conjugated to alkaline phosphatase.
Soluble samples were assayed forproteinaccording to (Bradford, 1976) and
membrane samples according to (Schaffner and Weissman, 1973) using
BSA as a standard.
Results
Loss ofVesicle MotorActivity during Purification
ofDynein
Since we determinedpreviously that chick embryo fibroblast
cytosol, but not highly purified chick embryo brain dynein,
could promote vesicle movement, we examined when in the
dynein purification the ability to move vesicles was lost. To
do this, the vesicle motor activities of different fractions
from the purification were measured quantitatively. For the
vesicle motility assay, membrane vesicles and a soluble frac-
tion were combined and examined by video-enhanced con-
trast light microscopy using an immobilized microtubule
substrate prepared by centrifuging taxol-stabilized microtu-
bules onto glass coverslips. Vesicle movements were counted
and activity was scored as the number of movements per
minute; the direction oftransport was determined on centro-
some microtubules (Schroer et al., 1988; Schroer et al.,
1989; see Materials and Methods).
The first steps in the dynein purification are cosedimenta-
tion with microtubules followed by ATP-dependent release.
No vesicle motor activity was detected in the initial brain ex-
tract. In contrast, the ATP release had a high level of vesicle
motor activity (Fig. 1 B and Table I; this represents both plus
end- and minus end-directed motility). Although the ATP
release contains kinesin and dynein which cause bidirec-
tional movement, as shown in Table II, vesicle movements
were predominantly (89%) toward microtubule minus ends.
The finding of a high level ofminus end-directed vesicle mo-
tor activity suggested that the ATP release, like cytosol, con-
tained accessory factors that activate dynein-driven vesicle
transport.
Vesicle MotorActivity of20S Dynein
Use ofvelocity sedimentation to further fractionate the ATP
release resolved two peaks of protein, one that sedimented
at 208 and the second that sedimented broadly near =9S.
The polypeptide composition of the sucrose gradient frac-
tions was analyzedby SDS-PAGE (Fig. 1 A, lanes 1-9), and,
as expected, the 20S peak contained the characteristic M,
440,000, 70,000, and 55,000 polypeptide subunits of cyto-
plasmic dynein (Paschal et al., 1987), as well as various mi-
nor components. The 9S component contained kinesin and
several other polypeptides, including high molecular weight
polypeptides that co-migrated with the heavy chain of dy-
1311Figure 1. Loss of vesicle motor activity during purification of
dynein . (A) Polypeptide compositions of the ATP release and su-
crose gradient fractions . ATPsensitive microtubule-binding pro-
teins (ATP release) were subjected to velocity sedimentation into
a5-20% linear sucrose gradient. The starting material and sucrose
gradient fractions were run on a 6% SDS-polyacrylamide minigel
that was stained with Coomassie blue . Lane R, ATP release ; lane
P, an aliquot(=1%) of the gradient pellet; lanes 1-9, fractions 1-9.
The 9S and 20S fractions are indicated in brackets. Molecular
weight markers (inkD) areon the left . DHC, Dynein heavy chain ;
M, =440,000. (B) The vesicle motor activities of the ATP release
(ATP Rel), 20S dynein (20S Dyn), MonoQ-purified dynein (MQ
Dyn), and the 9S fraction (9Salone; a pool of fractions 6, 7, and
8; bracketed) were measured . In samples ATP Rel, 20S Dyn, and
9S alone, the "motor mixture (see Materials and Methods) was
composed of equal parts motorand buffer. To detect any activity
of MonoQ dynein (MQ Dyn) the sample was assayed undiluted .
Bars +5, +6, +7, and +8 represent the activities of mixtures of
20S dynein with fraction 5, 6, 7, or 8. The data are the average
(meant SEM) of activity measurements from at least three inde-
pendent experiments . (C) The concentration dependence of 20S
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Table L Cytoplasmic Dynein Purification:
Vesicle MotorActivity
Activity : values for total vesicle motor activity are from the data in Fig . 1 B .
ATP release : activity is corrected for the fact that vesicle movements were
8996 minus end directed (Table 11) . 20S and MonoQ dynein activities are not
corrected because they were 10096 minus end directed (Table n) . The data are
the average of at least three independent experiments . Dynein concentration:
protein concentrations of 20S and MonoQ dynein were determined by protein
assay (see Materials and Methods) . The dynein concentration in the ATP
release was estimated by comparing the Coomassie blue staining intensity of
the dynein heavy chain on SDS-PAGE with a dynein standard . The concentra-
tions given represent the final dynein concentrations in the vesicle motility as-
say . At lower protein concentrations MonoQ dynein had undetectable vesicle
motor activity (see Fig . 3) .
nein . Compared with theATP release, 20S dynein (Fig. 1 A,
lanes 2-4) showed reduced ability tomove vesicles (Fig. 1B
and Table I), with all residual movements being minus end
directed . However, despite overall loss in vesicle motor ac-
tivity, 20S dynein retained full activity in a microtubule glid-
ing assay, promoting movement at a velocity of0.5 um/s as
reported previously (Lye et al ., 1987 ; Paschal et al ., 1987;
Schroer et al ., 1989) . We reported earlier that 20S dynein
alone was not sufficient for vesicle motility (Schroer et al .,
1989), butin that studydynein was assayed at concentrations
of <15 ELg/ml, significantly lower than the concentrations
used here (50-100 ,ug/ml ; see Materials and Methods) . We
have now determined the dose dependence of dynein con-
centration on vesicle motor activity (Fig. 1 C) ; activity in-
creases linearly with concentrations >15 jig/ml, explaining
the apparent discrepancy.
That more highly purified dynein retained full activity to
bind to andmove alongmicrotubules, butwasless active for
vesicle transport supported the view that one or more com-
ponents required to mediate vesicle movement were being
lost during purification . To examine this, 20S dynein was
recombined with other fractions from the sucrose gradient
and assayed for vesicle motility. As seen in Fig . 1 B, mixing
the enzyme with the 9S fractions resulted in restoration of
full vesicle motor activity, in which most movements were
minus end-directed (82% , Table In . Although the 9S com-
ponent by itself had low vesicle motor activity (Fig . 1 B),
the effect ofmixing 20Sdynein with the9S fractionswas syn-
ergistic because the activity of the mixture was greater than
the sum of the separate activities .
The discovery that vesicle motor activity increases with
increasing dynein concentration (Fig . 1 C) suggested that the
enhancement of minus end motility might be due to dynein
components in the9S fractions . However, this is notthe case .
dynein on vesicle motor activity was determined . Motility assay
sampleswere prepared in whichthemotormixturewas composed
of undiluted 20S dynein (60-110 pg/ml protein) or dynein diluted
1:2 or 1:4 with buffer. Vesicle motor activities were averaged (mean
t SEM) from four independent experiments. No motility was ob-
served at dynein concentrations less than 15 lag/ml .
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Sample
Minus end-directed
vesicle motor activity Dynein
Specific vesicle
motor activity
(movementslmin) (uglmb (activitylmglml dynein)
ATP release 11.7 38 308
20S dynein 2.6 26 100
MonoQ dynein 0.3 100 3Table II. Direction of Vesicle Movements
The direction of vesicle movements was determined using micrombules poly-
merized from centrosomes (see Materials and Methods) . Each sample was
tested in at least three independent experiments .
n, The total number of vesicle movements analyzed .
9S fraction, Pool of sucrose gradient fractions 6, 7, and 8 (see Fig. 1 A) .
ActivatorII, Pool E isolated by MonoQ chromatography ofthe 9S fraction (see
Fig . 6) .
No dynein polypeptides were detected in the 9S fractions
by immunoblot analysis with antibodies against the M
440,000 heavy chain and 70,000 intermediate chain poly-
peptides (mAbs 440.1 and 70.1; Steuer et al ., 1990 ; Steller
et al ., manuscript in preparation) . Further, following ex-
posure of the 9S fractions to vanadate-mediated UV pho-
tocleavage to inactivate dynein, the ability to stimulate vesi-
cle motility was retained (data not shown) indicating that the
activator(s) in the 9S fraction was a component other than
dynein .
Figure 2 . MonoQ chromatography of 20S dynein . (A) A representative column profile depicting absorbance at 280nm; only the portion
ofthe chromatographic run representing the KCl elution is shown . The salt gradient (80 to 400mM KCl) is superimposed on the absorbance
tracing . The eluate from 0 to 150mM KCl did not contain protein . Peaks 1, 2 (MonoQ Dynein), and 3 are indicated, containing 10, 70,
and 30 Ag/ml protein, respectively . (B) SDS-polyacrylamide gel analysis of the column load and elution profile. Fractions comprising
peaks 1, 2, and 3 are indicated in brackets . Lane L, the 20S dynein loaded on the column . Lanes containing column fractions 20-28 and
32-35 are labeled accordingly. All lanes contained equal amounts of sample. The 7.5% gel was stained with Coomassie blue. Molecular
weight markers (in kD) are indicated on the right . DHC, dynein heavy chain ; M, = 440,000.
Schroer and Sheetz Activators ofCytoplasmic Dynein and Kinesin
￿
1313
An Activatorof VesicleMotility in 20SDynein
The finding ofvesicle motor activity in the 20S fractions in-
dicated that some dynein in the preparation was active for
vesicle motility . This might result from the presence of a
dynein activator in the preparation or the permanent activa-
tion of a subpopulation of the enzyme, or both . To distin-
guishamong these possibilities 20S dynein was purified fur-
ther by ion exchange chromatography on a MonoQ column .
As seen in Fig . 2, MonoQ chromatography separated the
material into three major peaks of protein (Fig . 2 A ; peaks
1, 2, and 3) . SDS-PAGE analysis (Fig. 2B) showed peak 2
to contain exclusively theM 440,000 dynein heavy chain
plus the 70,000 and 55,000 dynein polypeptides (Fig. 2 B,
lanes 24-28) . We will refer to peak 2 as MonoQ dynein .
Trace amounts of dynein heavy chain also trailed into la-
ter column fractions . Peak 3 (Fig . 2 B, lanes 33-35) con-
tained major polypeptides of M, 50,000 and a doublet of M,
150,000 plus other components including a polypeptide of
M 45,000 that reacted with an anti-actin antibody on im-
munoblots (data not shown) . Peak 1 contained aM 45,000
protein (Fig . 2 B, lane 21) that also reacted with the anti-
actin antibody on immunoblots (data not shown) .
MonoQ dynein was assayed for motor activity in the
microtubule gliding and vesicle motility assays. Like 20S
dynein, MonoQ dynein promoted robust microtubule glid-
ing at a velocity of0.5 Am/s, but in contrast with 20S dynein
had nearly undetectable vesicle motor activity (Fig . 1 B;Fig.
3 and Table I) . The few vesicle movements observed were
Sample Minus end directed n
ATP release 89 62
20S dynein 100 42
MonoQ dynein 100 10
20S dynein + 9S fraction 82 95
20S dynein + Activator II 23 241
Activator II 14 159Figure 3. Identification ofAc-
tivator I . The vesicle motor
activities ofmixtures ofMonoQ
dynein with MonoQ peaks
1 and 3 (bars MQ + peak
1 and MQ + peak 3 ; equal
parts dynein and either peak)
were determined . The activi
ties of 20S dynein (20S ; =40 pg/ml), MonoQ dynein (MQ : =50
gg/ml) are shown for comparison (this concentration of MonoQ
dynein was insufficient for vesicle movement) . The data represent
the average values (mean f SEM) obtained from experiments per-
formed on at least three separate occasions .
minus end directed (Table II) . MonoQ dynein retained the
capacity to drive vesicle movement since activity could be
restored (5.8 t 0.7 movements/min) by addition of the 9S
fraction . In an attempt to identify the activator responsible
for the residual motility of 20S dynein, peaks 1 and 3 were
recombined withMonoQ dyneinusing a concentration of en-
zyme insufficient for vesicle motility (Fig . 3) . Peak 1 neither
stimulated motility when mixed with MonoQ dynein nor did
it have activity by itself. In contrast, the mixture of peak 3
and MonoQ dynein promoted minus end-directed vesicle
movements although peak 3 had little activity by itself . We
well refer to the activity in peak 3 as Activator I .
Effects ofDynein Activatorson Velocity of
VesicleMovements
Although the vesicle motor activity of dynein is increased
both by factors that sediment at 9S and by Activator I, the
two activators have different effects on the velocity of vesicle
movement . As seen in Fig . 4 and Table III, vesicle move-
ments driven by 20S dynein showed a mean velocity of 0.6
Am/s . On rare occasion, MonoQ dynein moved vesicles at
0.6 pm/s and the mixture ofMonoQ dynein with Activator
Figure 4. Velocities ofvesicle movements driven by 20S dynein and
20Sdyneinplus the 9S fractions . The histogram shows the distribu-
tion of velocities (jm/s) ofvesicle movements exhibited by the two
samples . For 20S dynein (®), the mean velocity (±SD) was 0.6 t
0.2 pm/s (N = 28) . For 20S dynein plus 9S fractions (o), the
mean velocity (fSD) was 0.8 f 0.3 (N = 51) . The velocities of
20S dynein vs. 20S dynein plus the 9S fraction or Activator II were
significantly different as determinedby t test (P > 0.001) . These data
are also listed in Table II .
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TableIN. Velocity of Vesicle Movements
Velocities were measured as described in Materials and Methods ; data were
collected from atleast four separate experiments for each sample . The distribu-
tion ofvelocities of 20S dynein and20S dynein plus the 9S fraction areshown
in Fig . 4 .
I promotedmovement at similar velocities to 20S dynein (Ta-
ble III) . The maximal velocity ofmovement was significantly
increased when 20S dynein was mixed with the 9S fraction
(Fig . 4), with vesicles having amean velocity of 0.8 pm/s and
some as fast as 2 .3 pm/s (Table III) . Thus, the dynein activa-
tor(s) present in the 9S fraction increase(s) both frequency
and velocity ofvesicle movements, while only the frequency
ofmovement is enhanced by Activator I .
Purified Dynein Causes Membranes toBind
to Microtubules
The requirement for dynein activators in vesicle motility
could arise from the inability of purified dynein to bind vesi-
cles effectively . To test whether dynein alone could interact
with membranes we examined mixtures with 20S orMonoQ
dynein and microtubules . As seen in Fig . 5, more vesicles
bound to microtubules (Fig. 5, B and C) than in the presence
of 20S dynein plus the 9S fractions (Fig . 5 A) . In addition
to promoting typical vesicle translocations (e.g ., Fig . 5 D),
20S dynein caused vesicles to undergo short, bidirectional
displacements of 41 um (Fig . 5 E) . These "tethered" move-
ments were unique to purified dyneins and were not ob-
served in the ATP release, mixtures of 20S dynein and the
9S fractions or in whole cytosol . If soluble protein (motor
and carrier protein ; see Materials and Methods) was omitted
from the assay, membranes also decorated microtubules but
no movement occurred . The observation that MonoQ-puri-
fied dynein induced vesicles to bind to microtubules suggests
that, in the absence ofactivators, dynein retains the capacity
to bind membranes .
An Activator in the 9S Fraction Stimulates
Minus End-directed Transport and Supports
Plus End-directed Transport
In an attempt to identify other dynein activator(s), the 9S
fraction was subjected to MonoQ chromatography, yielding
several distinct peaks ofprotein (Fig. 6 A) . The predominant
polypeptide in the starting mixture (Fig . 6 B, lane L), kine-
sin, trailed across the column in a broad peak (Fig . 6 C) .
MonoQ peaks A through H were desalted and assayed for
motor activity by themselves . Peaks A, B, and C all con-
tained the plus end motor kinesin (Fig . 6 C) and supported
microtubule gliding but not vesicle motility. In contrast,
peak E, whichwe will refer to as Activator II, supported vig-
orous vesiclemotility (Fig . 7) .On centrosome microtubules,
vesicle movements powered by Activator II alone were 87
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Sample
Velocity
(mean t SD)
(sm/s)
Range
(am/s)
n
20S dynein 0.6 t 0.2 0.2-1 .2 28
MonoQ dynein + 0.7 t 0.3 0.3-1 .2 20
Activator I
20S dynein + 9S 0.8 t 0.3 0.2-2 .3 51
20S dynein + Activator II 0.8 f 0.4 0.4-2 .1 46Figure 5 . Purified dynein causes membrane vesicles to bind to microtubules . Representative samples from the vesicle motility assay are
depicted in photographs taken from the video monitor. All samples contained microtubules, vesicles, motors, and ATP (as detailed in
Materials and Methods) . In the absence of added motors few vesicles bound to microtubules and the samples resembled A . (A) Assay
with 20S dynein plus the 9S fraction, showing the standard mixture of vesicles with the microtubule substrate . (B and C) Assay with 20S
dynein (B) orMonoQ dynein (C) alone . Many vesicles are boundtondcrotubules . (D andE) Sequential micrographs demonstrating vesicle
movements. (D) 20S dynein plus 9S fraction : a moving vesicle (arrowhead) is shown at 1-s intervals . (E) 20S dynein alone : The back
and forth movements of two vesicles (arrowheads) are shown at 8-s intervals . Bars, 1 um .
plus end directed (Table II), suggestive of kinesin (Fig. 6 C,
lane E) activity.
Activator II also stimulated the activity of20S dynein (Fig .
7), yielding a significant enhancement of minus end motility
(2 .1 minus end-directed movements/min vs . 0.2 minus
end-directed movements/min on centrosome microtubules) .
In some (but not all) experiments peak D (Fig . 6 B, lane D)
drove vesicle movements when mixed with dynein . (This
variability is likely to stem from the peak E activator con-
taminating the peakD fractions .) 20S dynein plus Activator
II promoted vesicle movements at the same mean velocity
(0.8 t 0.4 um/s ; Table III) and with a distribution similar
to 20S dynein plus the 9S fractions . Addition of 20S dynein
to Activator II did not affect plus end vesicle movements .
Schroerand Sheetz Activators of Cytoplasmic Dynein and Kinesin
Fig . 6 shows that Activator II elutes from the MonoQ
column at a salt concentration similar to that which elutes
dynein, and contains polypeptide bands in the molecular
weight range of cytoplasmic dynein heavy chain . However,
only trace levels of dynein could be detected in Activator II
by immunoblot analysis (mAbs 440.1 and 70.1 ; Steuer et al .,
1990 ; data not shown) . To further exclude the possibility that
dynein was responsible for its stimulatory effects, Activator
II was subjected to vanadate-mediated UVphotocleavage or
was UVirradiated under control conditions (Lye et al ., 1987;
Schroeretal ., 1989) . When comparedbySDS-PAGE, neither
sample contained the expected M, 220,000 and 190,000
UVcleavage fragments nor was loss of a high molecular
weight polypeptide detected . In mixtures with 20S dynein
1315Figure 6. MonoQ chromatography of9S fraction . (A)A representa-
tive column profile depicting absorbance at 280 nm ; only the por-
tion of the chromatographic run representing the KCI elution is
shown. The salt gradient (80 to 400 mM KCl) is superimposed on
the absorbance tracing . The eluate from 0 to 150 mM KCI did not
contain protein . (B) SDS-PAGE analysis of the column load and
KCI elution . Lanes A-H, peaks A through H, lane L, Pooled 9S
fractions (fractions 6 through 8 in Fig . 1A) loaded onto the column .
The 7.5 % gel was stained with Coomassie blue ; 15 I1 ofeach sam-
ple was loaded perlane. Molecular weight markers (in kD) are indi-
cated on the right . (C) Distribution of kinesin in the MonoQ
column fractions . PeaksA-Fwere analyzed by anti-kinesin immu-
noblot (mAb SUK4 ; Ingold et al ., 1988), the 9S fraction loaded on
the column (L) is also shown . Only the relative molecular weight
range ofkinesin heavy chain (M 116,000) is shown; the antibody
did not recognize any other polypeptides .
the two samples had similar vesicle motor activities (UV
cleaved : 16.5 t 1.5 movements/min ; control : 13.8 f 1.7
movements/min), as they did when assayed by themselves
(data not shown) . We conclude that the stimulatory effect of
Activator II on vesicle transport is not due to a low level of
an "activated" cytoplasmic dynein . Activator II is also dis-
tinct from Activator I, judging from the lack of reactivity on
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Figure 7 . Identification of Activator II . Vesicle motor activity of
20S dynein alone (20S Dynein ; = 40 gg/ml) and "motor mixtures
of 20S dynein plus the 9S fraction (+9S) or MonoQ peak A, C,
D, E, F, G, orH(+A-H) . Motor mixtures were composed of equal
parts 20S dynein and the peak indicated . The activity ofpeak E by
itself is also shown (E alone, diluted 1:2 with buffer) . The activity
of peakE plus 20S dynein was significantly greater than the sum
of the activities of 20S dynein and pool E by themselves as deter-
mined by t test (P > 0.05) .
immunoblots with an antibody against the Mr 150,000 dou-
blet component of Activator I (mAb 150.1 ; Steuer et al .,
1990 ; data not shown) . These findings suggest that Activator
II stimulates both kinesin and dynein-based vesicle motility.
Discussion
Cytoplasmic dynein drives intracellular processes such as
neurite extension, mitotic movements, and vesicle transport,
activities that must be carefully coordinated to ensure nor-
mal cell function . Using an assay for vesicle motility in vitro,
we showed previously that transport requires soluble factors
(activators) in addition to cytoplasmic dynein ; the latter pro-
vides motile force while the activators govern the overall
magnitude and velocity ofmovement . On the basis of their
ability to stimulate purified dynein tomove vesicles, we have
now identified Activators I and II, the first described regula-
tors of cytoplasmic dynein activity.
Activator Effects on Dynein
That purified dynein or kinesin immobilized on an inert an-
ionic surface has motor activity, while dynein bound to a
vesicle does not (Schroer et al ., 1988 ; 1989) indicates that
membrane binding inhibits motility unless necessary activa-
tors are available . It may be possible to glean insight into
mechanisms by which dynein activity is controlled by ex-
amining details of vesicle movement in the presence and ab-
sence of the two activators . Judging from the behavior of
vesicles in vitro, dynein can exist in multiple states when
complexed withmembranes and microtubules. The enzyme
is either immotile(MonoQ dynein alone), active but capable
of only basal motility (plus Activator I), or active at in-
creased velocity (plus Activator II), states whichmay corre-
late with dynein ATPase activity. The vesicle oscillations
promoted by highly purified dyneins may be similar to move-
ments of microtubules mediated by flagellar dyneinmade in-
capable of ATP hydrolysis (Vale et al., 1989) . Purified
dynein bound to vesicles and microtubules may be unable to
1316utilize energy owing to lack of the necessary activator(s) . A
detailed comparison of the vesicle oscillations and micro-
tubule movements has not yet been performed, so the mech-
anistic similarity of the two is unknown. Since motor ATPase
and resulting transport velocity are commonly coupled (Cohn
et al., 1987; Vale et al., 1984), the effects of Activator II
on velocity suggest further enhancement of dynein ATPase
activity.
Mechanismsfor Activation
Regulation of highly coordinated microtubule-based move-
ments such as bidirectional transport of pigment granules in
chromatophores (Rodzdial and Haimo, 1986; Thaler and
Haimo, 1990), sperm motility (Tash, 1989), and mitosis
(Moreno and Nurse, 1990) isunequivocally mediated by phos-
phorylation, although direct involvement of microtubule-
based motors is not proven. Such modification affects all
subunits of axonemal dynein (reviewed by King and Witman,
1989)and the M 70,000 intermediate chains of the cytoplas-
mic isoform (A. Adamson, M . Anderson, and T. Schroer,
unpublished results). Kinesin heavy and lightchains are both
phosphorylated in vitro (Buster, D., M . Lohka, and J. M.
Scholey. 1990. J. Cell Biol. 111:418a) as predicted from pri-
mary sequence analysis (Yanget al., 1989; Cyr, J. L., G. S.
Bloom, and S. T. Brady. 1990. J. Cell Biol. 111:146a). Since
the kinesin lightchain and dynein intermediate chains are lo-
cated distal to the microtubule-binding heads (Hirokawa et
al., 1989; Steuer etal., manuscriptinpreparation) theirphos-
phorylation may profoundly affect membrane, chromosome,
and/or spindle binding and consequent motility.
That even the major components of Activators I and II are
recovered in substoichiometric amounts compared with dy-
nein suggests a catalytic mechanism for activation. Altema-
tively, despite copurification with microtubule motors, sig-
nificant amounts of either activator may be lost earlier in the
dynein purification and in cells the activators may be present
in high concentration. Comparative immunoblot analysis of
dynein and the M, 150,000 polypeptide doublet reveals that
the two proteins are stoichiometric in brain tissue but that
significant amounts of dynactin are lost upon microtubule
binding and release (Gill et al., in press) . Further, judging
from its abundance, Activator I may function as a structural
component of the vesicle motor. However, it appears that
neither activator is required to bind dynein to membranes,
although it is not known whether the binding we observe
reflects a physiological interaction.
IdentityofActivatorPblypeptides
We concluded previously that kinesin plays a key role in bi-
directional vesicle transport since its immunodepletion from
axonal cytosol profoundly inhibits motility in both plus end
and minus end directions (Schroer et al., 1988) . Yet kinesin
by itself is not sufficient for vesicle motility (this report
and Schroer et al., 1988), nor can it serve as an activator of
dynein-driven vesicle motility, just as purified dynein does
not activate kinesin to move vesicles (see Fig. 7, bar C). Our
earlier findings are most consistent with the existence ofacti-
vators) shared by kinesin and cytoplasmic dynein, in keeping
with a model wherein the "vesicle motor" is a protein com-
plex composed of the two motors plus activator(s) (Sheetz
et al., 1989). Its stimulatory effects on both motors make
Schroer and Sheetz Activators of Cytoplastnic Dynein and Kinesin
Activator II an appropriate candidate for a shared activator,
further study of which awaits purification of the active com-
ponent.
Considering its simple polypeptide composition (assuming
a major component is an activator), identification of the ac-
tive polypeptide(s) in Activator I should be straightforward.
Ofpotential interest is the M, 150,000 component, common
in 20S dynein preparations (Neely and Boekelheide, 1988 ;
Schnapp and Reese, 1989; Hirokawa et al., 1990; Verde et
al ., 1991), which when adsorbed by mAb 150.1 prevents
stimulation of dynein-based vesicle motility by Activator I
(Gill et al ., in press). The M, 150,000 doublet is one com-
ponent of a complex formed by the Activator I polypeptides
(Fig. 2 B, peak 3), since all are removed by immunodepletion
(Gill et al., in press) and in hydrodynamic studies behave as
an aggregate of M > 106 (D. M. Eckley, D. Hammond and
T. Schroer, unpublished results) that sediments at =20S (Gill
et al., in press).
The primary structure of the M 150,000 component,
named dynactin, has been determined (Gill et al., in press;
Holzbaur et al., 1991) . The predicted protein structure con-
tains two highly conserved, a-helical coiled-coil domains, a
motif commonly found in proteins capable of homodimer-
ization (e.g., kinesin, myosin II, tropomyosin, spectrin and
intermediate filament proteins) . Of the two dynactin iso-
forms we observe, only the lower Mr species is brain
specific (Gill et al., in press; Steuer et al ., manuscript in
preparation), suggesting a specialized role in neurons. Dy-
nactin has extensive sequence homology to the Drosophila
protein Glued, which when mutated results in defects in ba-
sic cell function and neuronal development, as expected for
a required component of the vesicle transport machinery.
FurtherImplications
The participation of dynein in such diverse transport func-
tions as vesicle motility and mitosis raises interesting ques-
tions aboutmechanisms for coordination of enzyme activity.
Recent studies in Xenopus eggs demonstrate that dynein pro-
vides alternating roles during the cell cycle, promoting mem-
brane movements only in interphase extracts (Allan and
Vale, 1991), while in mitotic extracts prominent microtu-
bule-microtubule motility is observed (Verde et al., 1991) .
Coordinate regulation of these complementary activities is
thought to be mediated by cell cycle-dependent phosphoryla-
tion of components that target dynein to the appropriate or-
ganelle. Isolated as facilitators of vesicle motility in vitro,
Activators I and II are examples of factors that may enhance
the interaction of dynein with vesicles or other target(s) to
control activity in vivo.
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